‹ Screener

Balance Labs, Inc.

BLNC · Services-Management Consulting Services · 46.9M shares · -3%/yr ↓ buyback · EDGAR filings ↗

Grade

D45

gen composite 30pct→56; net margin <-100%; net + operating loss; negative equity (distress); weak liquidity, no op profit

Notable findings

Quarterly revenue

2022-06-30 · $68K2022-09-30 · $68K2022-12-31 · $45K2026-03-31 · $33K

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
100.0%
Operating margin
-218426.8%
Net margin
-529472.1%
Return on equity
940.9%
Return on assets
-7991.9%
Debt / equity
-0.0×
Current ratio
0.1×
Tangible book value
-$3M
Cash & investments
$398K
Stock comp / revenue
211673.3%

Notable events (8-K)

DateItems
2026-02-11Exec/director changeExhibitsfiling ↗
2025-12-16Exec/director changeExhibitsfiling ↗
2025-08-29Exec/director changeReg FDExhibitsfiling ↗
2024-12-13Auditor changeExhibitsfiling ↗
2024-07-10Exec/director changefiling ↗
2023-07-18Exec/director changefiling ↗
2022-11-03Auditor changeExhibitsfiling ↗
2022-07-22Exec/director changeExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
10-Q2026-05-152026-03-310001493152-26-023451 ↗
10-K2026-04-102025-12-310001493152-26-016088 ↗
8-K2026-02-112026-02-060001493152-26-006205 ↗
8-K2025-12-162025-12-120001493152-25-027957 ↗
10-Q2025-11-132025-09-300001493152-25-022345 ↗
8-K2025-08-292025-08-250001641172-25-025898 ↗
10-Q2025-08-142025-06-300001641172-25-023738 ↗
10-Q2025-05-202025-03-310001641172-25-011637 ↗
10-K2025-04-152024-12-310001641172-25-004842 ↗
8-K2024-12-132024-12-090001493152-24-049983 ↗
10-Q2024-11-192024-09-300001493152-24-046598 ↗
10-Q2024-08-122024-06-300001493152-24-031278 ↗